• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

GRK3 高表达与胰腺导管腺癌的预后良好相关。

High expression of GRK3 is associated with favorable prognosis in pancreatic ductal adenocarcinoma.

机构信息

Department of General Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences/Peking Union Medical College, Beijing, China.

Department of Pathology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences/Peking Union Medical College, Beijing, China.

出版信息

Pathol Res Pract. 2018 Feb;214(2):228-232. doi: 10.1016/j.prp.2017.11.013. Epub 2017 Nov 20.

DOI:10.1016/j.prp.2017.11.013
PMID:29254792
Abstract

BACKGROUND

It was found that G-protein-coupled receptor kinase 3 (GRK3) played key biological roles in some cancers. However, its associations with clinicopathologic features and prognosis in pancreatic ductal adenocarcinoma (PDAC) remain unknown.

METHODS AND METHODS

Expression of GRK3 was detected, using tissue microarray-based immunohistochemistry, in paired formalin-fixed paraffin-embedded tumor and non-tumor samples from 165 patients with PDAC after curative resection, and was further correlated with clinicopathologic parameters and cancer-specific survival (CSS).

RESULTS

It was shown that GRK3 expression was much lower in tumor than in non-tumor tissues. Moreover, expression of GRK3 in tumor tissues was significantly associated with gender and T stage. Univariately, high GRK3 expression was predictive for favorable CSS, along with some conventional clinicopathologic variables. In multivariate Cox regression test, GRK3 expression remained to be a significant prognostic marker for PDAC. Finally, combination of GRK3 with some clinicopathologic variables, especially N stage, obtained more precise prediction for CSS.

CONCLUSIONS

Our data suggested that expression of GRK3 was down-regulated in PDAC and was an independent prognostic factor.

摘要

背景

研究发现 G 蛋白偶联受体激酶 3(GRK3)在某些癌症中发挥着关键的生物学作用。然而,其与胰腺导管腺癌(PDAC)的临床病理特征和预后的关系尚不清楚。

方法和方法

使用组织微阵列免疫组织化学法,检测 165 例经根治性切除的 PDAC 患者配对的福尔马林固定石蜡包埋肿瘤和非肿瘤组织中 GRK3 的表达,并进一步与临床病理参数和癌症特异性生存(CSS)相关联。

结果

结果表明,GRK3 在肿瘤组织中的表达明显低于非肿瘤组织。此外,肿瘤组织中 GRK3 的表达与性别和 T 分期显著相关。单变量分析显示,高 GRK3 表达与 CSS 预后良好相关,同时与一些传统的临床病理变量相关。多变量 Cox 回归试验表明,GRK3 表达仍然是 PDAC 的一个显著预后标志物。最后,GRK3 表达与一些临床病理变量的结合,特别是 N 分期,对 CSS 的预测更为准确。

结论

我们的数据表明,GRK3 在 PDAC 中表达下调,是一个独立的预后因素。

相似文献

1
High expression of GRK3 is associated with favorable prognosis in pancreatic ductal adenocarcinoma.GRK3 高表达与胰腺导管腺癌的预后良好相关。
Pathol Res Pract. 2018 Feb;214(2):228-232. doi: 10.1016/j.prp.2017.11.013. Epub 2017 Nov 20.
2
Claudin-4 expression predicts survival in pancreatic ductal adenocarcinoma.Claudin-4 的表达可预测胰腺导管腺癌的生存情况。
Ann Surg Oncol. 2012 Jul;19 Suppl 3:S491-9. doi: 10.1245/s10434-011-1970-2. Epub 2011 Aug 12.
3
N-wasp in pancreatic ductal adenocarcinoma: associations with perineural invasion and poor prognosis.N-黄蜂在胰腺导管腺癌中的作用:与神经周围侵犯及预后不良的关联
World J Surg. 2014 Aug;38(8):2126-31. doi: 10.1007/s00268-014-2500-8.
4
Sineoculis homeobox homolog 1 protein overexpression as an independent biomarker for pancreatic ductal adenocarcinoma.Sineoculis homeobox homolog 1 蛋白过表达可作为胰腺导管腺癌的独立生物标志物。
Exp Mol Pathol. 2014 Feb;96(1):54-60. doi: 10.1016/j.yexmp.2013.11.003. Epub 2013 Nov 18.
5
DEK protein overexpression predicts poor prognosis in pancreatic ductal adenocarcinoma.DEK蛋白过表达预示胰腺导管腺癌预后不良。
Oncol Rep. 2017 Feb;37(2):857-864. doi: 10.3892/or.2016.5302. Epub 2016 Dec 8.
6
Ezrin protein overexpression predicts the poor prognosis of pancreatic ductal adenocarcinomas.埃兹蛋白过表达预示胰腺导管腺癌预后不良。
Exp Mol Pathol. 2015 Feb;98(1):1-6. doi: 10.1016/j.yexmp.2014.11.003. Epub 2014 Nov 5.
7
Clinicopathological and prognostic significance of MKK4 and MKK7 in resectable pancreatic ductal adenocarcinoma.可切除胰腺导管腺癌中 MKK4 和 MKK7 的临床病理和预后意义。
Hum Pathol. 2019 Apr;86:143-154. doi: 10.1016/j.humpath.2018.11.026. Epub 2018 Dec 9.
8
Increased expression of valosin-containing protein (p97) is associated with lymph node metastasis and prognosis of pancreatic ductal adenocarcinoma.含缬酪肽蛋白(p97)表达增加与胰腺导管腺癌的淋巴结转移及预后相关。
Ann Surg Oncol. 2004 Feb;11(2):165-72. doi: 10.1245/aso.2004.05.012.
9
RACK1 overexpression associates with pancreatic ductal adenocarcinoma growth and poor prognosis.RACK1过表达与胰腺导管腺癌的生长及不良预后相关。
Exp Mol Pathol. 2016 Oct;101(2):176-186. doi: 10.1016/j.yexmp.2016.08.001. Epub 2016 Aug 3.
10
Expression and prognosis value of SHP2 in patients with pancreatic ductal adenocarcinoma.SHP2在胰腺导管腺癌患者中的表达及预后价值
Tumour Biol. 2016 Jun;37(6):7853-9. doi: 10.1007/s13277-015-4675-5. Epub 2015 Dec 23.

引用本文的文献

1
TRIM58 downregulation maintains stemness via MYH9-GRK3-YAP axis activation in triple-negative breast cancer stem cells.TRIM58 下调通过 MYH9-GRK3-YAP 轴激活维持三阴性乳腺癌干细胞干性。
Cancer Gene Ther. 2024 Aug;31(8):1186-1200. doi: 10.1038/s41417-024-00780-w. Epub 2024 May 7.
2
Quantitative proteomics assay reveals G protein-coupled receptor kinase 4-induced HepG2 cell growth inhibition.定量蛋白质组学分析揭示G蛋白偶联受体激酶4诱导的HepG2细胞生长抑制。
Heliyon. 2024 Apr 12;10(8):e29514. doi: 10.1016/j.heliyon.2024.e29514. eCollection 2024 Apr 30.
3
GRK3 is a poor prognosticator and serves as a therapeutic target in advanced gastric adenocarcinoma.
GRK3 是一种预后不良的标志物,可作为晚期胃腺癌的治疗靶点。
J Exp Clin Cancer Res. 2022 Aug 23;41(1):257. doi: 10.1186/s13046-022-02463-6.
4
GRK3 as a Prognosis Biomarker in Gastric Cancer.GRK3作为胃癌的一种预后生物标志物。
J Cancer. 2022 Jan 31;13(4):1299-1306. doi: 10.7150/jca.64748. eCollection 2022.
5
Gα15 in early onset of pancreatic ductal adenocarcinoma.Gα15 在胰腺导管腺癌的早期发病机制中的作用。
Sci Rep. 2021 Jul 21;11(1):14922. doi: 10.1038/s41598-021-94150-3.
6
Plasminogen Activator Inhibitor 1 as a Poor Prognostic Indicator in Resectable Pancreatic Ductal Adenocarcinoma.纤溶酶原激活物抑制剂 1 作为可切除胰腺导管腺癌不良预后指标的研究。
Chin Med J (Engl). 2018 Dec 20;131(24):2947-2952. doi: 10.4103/0366-6999.247211.